Mylan launches EpiPen generic at $300 percent two-pack
Mylan, which first announced it would launch the generic version of its allergy auto-injector EpiPen for $300 in August, said the authorized generic would be available in pharmacies starting next week. Mylan's move comes a day after 20 U.S. states filed a lawsuit over pricing against generic drugmakers, including Mylan, Teva Pharmaceuticals and four other generic drugmakers. The U.S. Department of Justice on Wednesday filed criminal charges against two generic drug industry executives, alleging that they colluded to fix prices and split up market share.
